Low-dose interleukin-2 therapy in refractory systemic lupus...

The Lancet Rheumatology 2019 / 09 Vol. 1; Iss. 1

Low-dose interleukin-2 therapy in refractory systemic lupus erythematosus: an investigator-initiated, single-centre phase 1 and 2a clinical trial

Humrich, Jens Y, von Spee-Mayer, Caroline, Siegert, Elise, Bertolo, Martina, Rose, Angelika, Abdirama, Dimas, Enghard, Philipp, Stuhlmüller, Bruno, Sawitzki, Birgit, Huscher, Dörte, Hiepe, Falk, Alexa
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
1
Language:
english
Journal:
The Lancet Rheumatology
DOI:
10.1016/S2665-9913(19)30018-9
Date:
September, 2019
File:
PDF, 397 KB
english, 2019
Conversion to is in progress
Conversion to is failed